Splicing factor YBX1 regulates bone marrow stromal cell fate during aging
The EMBO Journal · 2023
DOI: 10.15252/embj.2022111762 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von Ye Xiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteoporosis. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: China Postdoctoral Science Foundation, China Postdoctoral Science Foundation | National Postdoctoral Program for Innovative Talents, Hunan Provincial Science and Technology Department.
Abstract (Originalsprache)
Senescence and altered differentiation potential of bone marrow stromal cells (BMSCs) lead to age-related bone loss. As an important posttranscriptional regulatory pathway, alternative splicing (AS) regulates the diversity of gene expression and has been linked to induction of cellular senescence. However, the role of splicing factors in BMSCs during aging remains poorly defined. Herein, we found that the expression of the splicing factor Y-box binding protein 1 (YBX1) in BMSCs decreased with aging in mice and humans. YBX1 deficiency resulted in mis-splicing in genes linked to BMSC osteogenic differentiation and senescence, such as Fn1, Nrp2, Sirt2, Sp7, and Spp1, thus contributing to BMSC senescence and differentiation shift during aging. Deletion of Ybx1 in BMSCs accelerated bone loss in mice, while its overexpression stimulated bone formation. Finally, we identified a small compound, sciadopitysin, which attenuated the degradation of YBX1 and bone loss in old mice. Our study demonstrated that YBX1 governs cell fate of BMSCs via fine control of RNA splicing and provides a potential therapeutic target for age-related osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.
- Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
ORCID-Profile: Ye Xiao, Yong-Jun Zheng, Mi Yang
Förderung
- China Postdoctoral Science Foundation
- China Postdoctoral Science Foundation | National Postdoctoral Program for Innovative Talents
- Hunan Provincial Science and Technology Department
- National Natural Science Foundation of China
Zitieren
APA
Xiao, Y., Cai, G. P., Feng, X., Li, Y. J., Guo, W. H., Guo, Q., Huang, Y., Su, T., Li, C. J., Luo, X. H., Zheng, Y. J., & Yang, M. (2023). Splicing factor YBX1 regulates bone marrow stromal cell fate during aging. The EMBO Journal. https://doi.org/10.15252/embj.2022111762
Vancouver
Xiao Y, Cai GP, Feng X, Li YJ, Guo WH, Guo Q, et al. Splicing factor YBX1 regulates bone marrow stromal cell fate during aging. The EMBO Journal. 2023. doi:10.15252/embj.2022111762
BibTeX
@article{Xiao2023,
author = {Xiao, Ye and Cai, Guang-Ping and Feng, Xu and Li, Yu-Jue and Guo, Wan-Hui and Guo, Qi and Huang, Yan and Su, Tian and Li, Chang-Jun and Luo, Xiang-Hang and Zheng, Yong-Jun and Yang, Mi},
title = {Splicing factor YBX1 regulates bone marrow stromal cell fate during aging},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2022111762}
}
EUVIMED